• Spina bifida – incomplete closure of the spinal column, which can lead to nerve damage.
• Anencephaly – severe under‑development of the brain and skull; infants are usually stillborn or die shortly after birth.
• Encephalocele – a sac‑like protrusion of brain tissue through an opening in the skull.

NTDs affect approximately 1 in every 1,000 live births worldwide (World Health Organization, 2022). In the United States, the incidence is about 7 per 10,000 births, with spina bifida being the most frequent form (CDC, 2023). Both sexes are affected, though some studies suggest a slightly higher prevalence in females for spina bifida.

Symptoms

Symptoms vary dramatically depending on the type and severity of the defect and whether the baby is still in utero, a newborn, or an older child/adult.

Spina Bifida

• Physical signs at birth: a hairless patch of skin, a dimple, or a cyst (meningocele) on the lower back.
• Neurological deficits: weakness or paralysis of the legs, loss of sensation, bowel or bladder dysfunction.
• Orthopedic problems: scoliosis, clubfoot, hip dislocation.
• Hydrocephalus (fluid buildup in the brain) in up to 80% of severe cases, causing an enlarged head and increased intracranial pressure.

Anencephaly

• Absence of a major portion of the skull and brain.
• Severe developmental delay; the infant is usually unresponsive.
• Most neonates are stillborn or survive only a few hours to days.

Encephalocele

• Visible sac or mass on the scalp, often at the back of the head.
• Neurological problems ranging from seizures, developmental delays, to visual or hearing loss, depending on the brain tissue involved.

General Symptoms in Older Children/Adults with Spina Bifida

• Chronic back pain.
• Urinary tract infections (UTIs) due to neurogenic bladder.
• Pressure sores (decubitus ulcers) from reduced sensation.
• Learning difficulties or attention‑deficit disorders.

Causes and Risk Factors

NTDs are multifactorial – genetics, nutrition, and environmental exposures all play a role.

Genetic Factors

• Mutations in genes involved in folate metabolism (e.g., MTHFR C677T).
• Family history: siblings of an affected child have a 2–5% recurrence risk.

Nutritional Factors

• Folate deficiency is the most well‑documented modifiable risk factor. Women who do not consume at least 400 µg of folic acid daily have a 2–3‑fold higher risk of having a baby with an NTD (NIH, 2021).
• Low vitamin B12 levels can exacerbate folate deficiency.

Maternal Health & Lifestyle

• Pre‑gestational diabetes (especially poorly controlled) increases risk 3‑fold.
• Obesity (BMI ≥ 30) raises risk by ~1.5–2 times.
• Use of certain anti‑seizure medications (e.g., valproic acid, carbamazepine) during the first trimester.
• Exposure to high‑dose folate antagonists (e.g., methotrexate) or certain environmental toxins (e.g., pesticides).

Other Factors

• Maternal hyperthermia (fever > 101 °F) during early pregnancy.
• Low socioeconomic status and limited access to prenatal care.

Diagnosis

Early detection allows for better planning and, for some defects, intrauterine treatment.

Prenatal Screening

• Maternal serum alpha‑fetoprotein (AFP) test – elevated AFP at 15–20 weeks’ gestation suggests an open NTD.
• Ultrasound – a detailed anatomy scan (18–22 weeks) can visualize spinal or cranial defects directly.
• Amniocentesis – measures AFP and acetylcholinesterase in amniotic fluid; also allows genetic testing.

Postnatal Diagnosis

• Physical examination – identification of skin stigmata, sac-like protrusions, or cranial abnormalities.
• Neuroimaging:
  • Ultrasound (in newborns with open fontanelles).
  • MRI – gold standard for detailed assessment of spinal cord, brain structures, and associated hydrocephalus.
• Urodynamic studies – evaluate bladder function in spina bifida patients.

Treatment Options

Treatment is individualized based on defect type, severity, and the patient’s age.

Surgical Interventions

• In‑utero repair (performed between 19–26 weeks) – closed spina bifida lesions before birth, reducing the need for postnatal shunting and improving motor outcomes (MOMS trial, NEJM 2011).
• Postnatal closure – within 48 hours of birth for open spina bifida to protect neural tissue and reduce infection risk.
• Ventriculoperitoneal (VP) shunt – placed to treat hydrocephalus; alternative endoscopic third ventriculostomy may be considered.
• Orthopedic surgeries – address scoliosis, clubfoot, or hip dislocation.

Medications

• Folinic acid (5‑MTHF) – high‑dose supplementation (up to 15 mg daily) for children with spina bifida to improve neurocognitive outcomes.
• Anticholinergics (e.g., oxybutynin) – manage neurogenic bladder.
• Antibiotics – prophylaxis for recurrent UTIs.
• Analgesics & muscle relaxants for spasticity.

Therapies & Lifestyle Measures

• Physical therapy – maintain strength, improve mobility, and prevent contractures.
• Occupational therapy – assist with daily living skills.
• Speech and language therapy – especially for children with associated cognitive delays.
• Bladder management (clean intermittent catheterization) to preserve kidney function.

Supportive Care

• Psychological counseling for patients and families.
• Educational accommodations – individualized education plans (IEPs) when learning difficulties arise.

Living with Neural Tube Defect

Practical day‑to‑day strategies help maximize independence and quality of life.

Mobility & Accessibility

• Use of assistive devices (wheelchairs, walkers, orthotic braces) as recommended by a physiatrist.
• Home modifications: ramps, grab bars, and accessible bathroom fixtures.

Skin Care

• Inspect skin daily for pressure sores, especially over numb areas.
• Reposition every 2 hours if wheelchair‑bound; use pressure‑relieving cushions.

Bladder & Bowel Management

• Follow a scheduled clean intermittent catheterization program.
• Fiber‑rich diet, adequate hydration, and scheduled bowel programs to avoid constipation.

Nutrition

• Maintain a balanced diet rich in folate (leafy greens, legumes, fortified cereals) throughout life.
• For overweight individuals, aim for a healthy BMI to lessen joint stress.

Regular Follow‑up

• Annual MRI or as directed by a neurologist to monitor spinal cord health.
• Routine urology visits to assess kidney function (ultrasound, serum creatinine).
• Neurosurgical reviews for shunt function if a VP shunt is present.

Prevention

Most NTDs are preventable with appropriate preconception and early‑pregnancy measures.

• Folic acid supplementation: 400 µg daily for all women of childbearing age; 4 mg (4000 µg) daily for those with a prior NTD‑affected pregnancy or known folate‑metabolism gene variants (CDC, 2023).
• Consume a folate‑rich diet (spinach, broccoli, citrus, fortified grains).
• Control chronic conditions:
  • Maintain blood glucose < 120 mg/dL (HbA1c < 6.5%) before conception for diabetic women.
  • Achieve a healthy weight (BMI < 25) prior to pregnancy.
• Review medications with a provider; switch away from high‑risk anti‑seizure drugs when possible.
• Avoid teratogenic exposures: smoking, excessive alcohol, certain pesticides, and high‑dose vitamin A.
• Early prenatal care: first‑trimester ultrasound and AFP testing can detect problems sooner.

Complications

If left untreated or poorly managed, NTDs can lead to serious health issues.

• Hydrocephalus – may cause brain damage, seizures, and visual impairment.
• Neurological deterioration – progressive loss of motor function or sensation.
• Renal failure – secondary to chronic neurogenic bladder and recurrent infections.
• Orthopedic deformities – severe scoliosis, hip subluxation, and chronic pain.
• Psychosocial impact – depression, anxiety, and reduced social participation.
• Infection – meningitis or wound infection after surgical repair, particularly if skin coverage is compromised.

When to Seek Emergency Care

Sources: Mayo Clinic, Centers for Disease Control and Prevention (CDC), National Institutes of Health (NIH), World Health Organization (WHO), Cleveland Clinic, “Management of Spina Bifida” – New England Journal of Medicine (2011), and relevant peer‑reviewed journals.